CRVL Fundamental Analysis - CORVEL CORP

Fundamental Rating

We assign a fundamental rating of 6 out of 10 to CRVL. CRVL was compared to 101 industry peers in the Health Care Providers & Services industry. CRVL has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. CRVL is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year CRVL was profitable.

In the past year CRVL had a positive cash flow from operations.

CRVL had positive earnings in each of the past 5 years.

In the past 5 years CRVL always reported a positive cash flow from operatings.

1.2 Ratios

CRVL has a Return On Assets of 16.88%. This is amongst the best in the industry. CRVL outperforms 99.01% of its industry peers.

With an excellent Return On Equity value of 29.43%, CRVL belongs to the best of the industry, outperforming 93.07% of the companies in the same industry.

Looking at the Return On Invested Capital, with a value of 28.10%, CRVL belongs to the top of the industry, outperforming 98.02% of the companies in the same industry.

The Average Return On Invested Capital over the past 3 years for CRVL is significantly above the industry average of 9.33%.

		Industry Rank	Sector Rank
ROA	16.88%
ROE	29.43%
ROIC	28.1%

ROA(3y)17.02%

ROA(5y)15.59%

ROE(3y)31.06%

ROE(5y)29.09%

ROIC(3y)28.6%

ROIC(5y)26.25%

1.3 Margins

The Profit Margin of CRVL (10.98%) is better than 94.06% of its industry peers.

In the last couple of years the Profit Margin of CRVL has grown nicely.

CRVL's Operating Margin of 13.94% is amongst the best of the industry. CRVL outperforms 83.17% of its industry peers.

In the last couple of years the Operating Margin of CRVL has grown nicely.

The Gross Margin of CRVL (23.79%) is comparable to the rest of the industry.

In the last couple of years the Gross Margin of CRVL has grown nicely.

		Industry Rank	Sector Rank
OM	13.94%
PM (TTM)	10.98%
GM	23.79%

OM growth 3Y1.04%

OM growth 5Y5.65%

PM growth 3Y1.12%

PM growth 5Y5.84%

GM growth 3Y-0.17%

GM growth 5Y1.95%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CRVL is creating value.

The number of shares outstanding for CRVL remains at a similar level compared to 1 year ago.

CRVL has less shares outstanding than it did 5 years ago.

CRVL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 13.72 indicates that CRVL is not in any danger for bankruptcy at the moment.

CRVL's Altman-Z score of 13.72 is amongst the best of the industry. CRVL outperforms 97.03% of its industry peers.

There is no outstanding debt for CRVL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Altman-Z	13.72

ROIC/WACC3.24

WACC8.66%

2.3 Liquidity

A Current Ratio of 1.79 indicates that CRVL should not have too much problems paying its short term obligations.

The Current ratio of CRVL (1.79) is better than 66.34% of its industry peers.

CRVL has a Quick Ratio of 1.79. This is a normal value and indicates that CRVL is financially healthy and should not expect problems in meeting its short term obligations.

With a decent Quick ratio value of 1.79, CRVL is doing good in the industry, outperforming 67.33% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.79
Quick Ratio	1.79

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 30.39% over the past year.

CRVL shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.86% yearly.

Looking at the last year, CRVL shows a quite strong growth in Revenue. The Revenue has grown by 12.46% in the last year.

Measured over the past years, CRVL shows a quite strong growth in Revenue. The Revenue has been growing by 8.62% on average per year.

EPS 1Y (TTM)30.39%

EPS 3Y14.48%

EPS 5Y16.86%

EPS Q2Q%27.95%

Revenue 1Y (TTM)12.46%

Revenue growth 3Y11.49%

Revenue growth 5Y8.62%

Sales Q2Q%10.86%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 38.26 indicates a quite expensive valuation of CRVL.

CRVL's Price/Earnings ratio is in line with the industry average.

CRVL is valuated rather expensively when we compare the Price/Earnings ratio to 27.69, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	38.26
Fwd PE	N/A

4.2 Price Multiples

CRVL's Enterprise Value to EBITDA ratio is in line with the industry average.

CRVL's Price/Free Cash Flow ratio is in line with the industry average.

		Industry Rank	Sector Rank
P/FCF	38.53
EV/EBITDA	22.63

4.3 Compensation for Growth

The excellent profitability rating of CRVL may justify a higher PE ratio.

PEG (NY)N/A

PEG (5Y)2.27

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for CRVL!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

CORVEL CORP

NASDAQ:CRVL (10/20/2025, 8:00:01 PM)

After market: 73.84 0 (0%)

73.84

+2.36 (+3.3%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)07-28 2025-07-28

Earnings (Next)11-03 2025-11-03

Inst Owners54.46%

Inst Owner Change0.23%

Ins Owners7.1%

Ins Owner Change-0.59%

Market Cap3.79B

Analysts0

Price TargetN/A

Short Float %2.37%

Short Ratio3.73

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	38.26
Fwd PE	N/A
P/S	4.12
P/FCF	38.53
P/OCF	26.7
P/B	11.06
P/tB	12.41
EV/EBITDA	22.63

EPS(TTM)1.93

EY2.61%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)1.92

FCFY2.6%

OCF(TTM)2.77

OCFY3.74%

SpS17.9

BVpS6.68

TBVpS5.95

PEG (NY)N/A

PEG (5Y)2.27

Profitability

		Industry Rank	Sector Rank
ROA	16.88%
ROE	29.43%
ROCE	35.36%
ROIC	28.1%
ROICexc	63.53%
ROICexgc	82.75%
OM	13.94%
PM (TTM)	10.98%
GM	23.79%
FCFM	10.71%

ROA(3y)17.02%

ROA(5y)15.59%

ROE(3y)31.06%

ROE(5y)29.09%

ROIC(3y)28.6%

ROIC(5y)26.25%

ROICexc(3y)48.46%

ROICexc(5y)45.93%

ROICexgc(3y)62.9%

ROICexgc(5y)61.44%

ROCE(3y)35.98%

ROCE(5y)33.03%

ROICexcg growth 3Y4.75%

ROICexcg growth 5Y18.9%

ROICexc growth 3Y6.87%

ROICexc growth 5Y18.29%

OM growth 3Y1.04%

OM growth 5Y5.65%

PM growth 3Y1.12%

PM growth 5Y5.84%

GM growth 3Y-0.17%

GM growth 5Y1.95%

F-Score8

Asset Turnover1.54

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Debt/EBITDA	0
Cap/Depr	143.25%
Cap/Sales	4.74%
Interest Coverage	250
Cash Conversion	89.54%
Profit Quality	97.54%
Current Ratio	1.79
Quick Ratio	1.79
Altman-Z	13.72

F-Score8

WACC8.66%

ROIC/WACC3.24

Cap/Depr(3y)112.41%

Cap/Depr(5y)107.09%

Cap/Sales(3y)3.78%

Cap/Sales(5y)3.81%

Profit Quality(3y)90.78%

Profit Quality(5y)99.01%

High Growth Momentum

Growth

EPS 1Y (TTM)30.39%

EPS 3Y14.48%

EPS 5Y16.86%

EPS Q2Q%27.95%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)12.46%

Revenue growth 3Y11.49%

Revenue growth 5Y8.62%

Sales Q2Q%10.86%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y31.08%

EBIT growth 3Y12.65%

EBIT growth 5Y14.76%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y49.21%

FCF growth 3Y34.78%

FCF growth 5Y13.57%

OCF growth 1Y59.6%

OCF growth 3Y23.73%

OCF growth 5Y9.51%

CORVEL CORP (CRVL) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens